Literature DB >> 7931425

Extreme variability of clinical symptoms among sibs in a MELAS family correlated with heteroplasmy for the mitochondrial A3243G mutation.

D de Vries1, I de Wijs, W Ruitenbeek, J Begeer, P Smit, H Bentlage, B van Oost.   

Abstract

In a family with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes with extremely varying clinical expression, we have identified the A3243G heteroplasmic point mutation in mitochondrial DNA. The degree of severity of the clinical symptoms in the various family members was reflected in the relative quantity of mutated mitochondrial DNA in different tissues. The biochemical activity of complex I of the respiratory chain in muscle was decreased in some members of this family.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7931425     DOI: 10.1016/0022-510x(94)90014-0

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  10 in total

Review 1.  Mitochondrial threshold effects.

Authors:  Rodrigue Rossignol; Benjamin Faustin; Christophe Rocher; Monique Malgat; Jean-Pierre Mazat; Thierry Letellier
Journal:  Biochem J       Date:  2003-03-15       Impact factor: 3.857

2.  Random genetic drift determines the level of mutant mtDNA in human primary oocytes.

Authors:  D T Brown; D C Samuels; E M Michael; D M Turnbull; P F Chinnery
Journal:  Am J Hum Genet       Date:  2000-12-29       Impact factor: 11.025

Review 3.  [Mitochondrial hearing impairment. Background, genetic predisposition and possibilities for diagnosis].

Authors:  K Riemann; M Pfister; N Blin; S Kupka
Journal:  HNO       Date:  2004-06       Impact factor: 1.284

4.  Genetic and biochemical impairment of mitochondrial complex I activity in a family with Leber hereditary optic neuropathy and hereditary spastic dystonia.

Authors:  D D De Vries; L N Went; G W Bruyn; H R Scholte; R M Hofstra; P A Bolhuis; B A van Oost
Journal:  Am J Hum Genet       Date:  1996-04       Impact factor: 11.025

5.  MtSNPscore: a combined evidence approach for assessing cumulative impact of mitochondrial variations in disease.

Authors:  Anshu Bhardwaj; Mitali Mukerji; Shipra Sharma; Jinny Paul; Chaitanya S Gokhale; Achal K Srivastava; Shrish Tiwari
Journal:  BMC Bioinformatics       Date:  2009-08-27       Impact factor: 3.169

6.  New evidence confirms that the mitochondrial bottleneck is generated without reduction of mitochondrial DNA content in early primordial germ cells of mice.

Authors:  Liqin Cao; Hiroshi Shitara; Michihiko Sugimoto; Jun-Ichi Hayashi; Kuniya Abe; Hiromichi Yonekawa
Journal:  PLoS Genet       Date:  2009-12-04       Impact factor: 5.917

7.  Deletion-mutant mtDNA increases in somatic tissues but decreases in female germ cells with age.

Authors:  Akitsugu Sato; Kazuto Nakada; Hiroshi Shitara; Atsuko Kasahara; Hiromichi Yonekawa; Jun-Ichi Hayashi
Journal:  Genetics       Date:  2007-12       Impact factor: 4.562

8.  Selection against pathogenic mtDNA mutations in a stem cell population leads to the loss of the 3243A-->G mutation in blood.

Authors:  Harsha Karur Rajasimha; Patrick F Chinnery; David C Samuels
Journal:  Am J Hum Genet       Date:  2008-02       Impact factor: 11.025

9.  Mitochondrial DNA mutations in renal cell carcinomas revealed no general impact on energy metabolism.

Authors:  D Meierhofer; J A Mayr; K Fink; N Schmeller; B Kofler; W Sperl
Journal:  Br J Cancer       Date:  2006-01-30       Impact factor: 7.640

10.  A wide range of 3243A>G/tRNALeu(UUR) (MELAS) mutation loads may segregate in offspring through the female germline bottleneck.

Authors:  Francesco Pallotti; Giorgio Binelli; Raffaella Fabbri; Maria L Valentino; Rossella Vicenti; Maria Macciocca; Sabina Cevoli; Agostino Baruzzi; Salvatore DiMauro; Valerio Carelli
Journal:  PLoS One       Date:  2014-05-07       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.